RecruitingPhase 3NCT04574089

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

Medical Ethics Committee of Peking University Shenzhen Hospital

Sponsor

Peking University Shenzhen Hospital

Enrollment

50 participants

Start Date

May 1, 2020

Study Type

INTERVENTIONAL

Conditions

Vaginitis

Summary

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Experimental: Baofukang Suppository 14 days and a drug called Experimental: Baofukang Suppository 7 days for people with vaginitis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.